Beyond the gene: Targeting neuroinflammation in Huntington's disease

Thank you.

Welcome to the MDS Podcast, the official podcast of the International Parkinson and Movement Disorders Society.

I am your host, Sara Camargos, from the Federal University of Minas Gerais, Brazil.

Today, our guest speaker is Dr. Rajir Kumar from the Rocky Mountain Movement Disorders Center, Colorado, USA.

He is the lead investigator and correspondent author of Movement Disorders Journal paper, an open-label Phase 1b study of safety pharmacokinetics and pharmacodynamics and clinical activity of ANX005 in patients with Huntington's disease.

Thank you, Dr. Kumar, for joining us today.

It's a pleasure to be here.

Thank you.

Thank you.

Welcome to the MDS Podcast, the official podcast of the International Parkinson and Movement Disorders Society.

I am your host, Sara Camargos, from the Federal University of Minas Gerais, Brazil.

Today, our guest speaker is Dr. Rajir Kumar from the Rocky Mountain Movement Disorders Center, Colorado, USA.

He is the lead investigator and correspondent author of Movement Disorders Journal paper, an open-label Phase 1b study of safety pharmacokinetics and pharmacodynamics and clinical activity of ANX005 in patients with Huntington's disease.

Thank you, Dr. Kumar, for joining us today.

It's a pleasure to be here.

Thank you.